Thomas Massie actually said...

We just simply cannot go down that path of eliminating any potential cure for some of these serious diseases.

Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focused.

H.R. 3 really would completely gut the pharmaceutical innovations which we all so desperately need and we rely upon.

I ask unanimous consent to submit into the record two press releases from the U.S. Post Office.